Junctional bradycardia medical therapy

Jump to navigation Jump to search

Junctional bradycardia Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Junctional bradycardia from other Disorders

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

EKG Examples

Chest X Ray

Echocardiography

Cardiac MRI

Coronary Angiography

Treatment

Medical Therapy

Electrical Cardioversion

Ablation

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Junctional bradycardia medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Junctional bradycardia medical therapy

CDC onJunctional bradycardia medical therapy

Junctional bradycardia medical therapy in the news

Blogs on Junctional bradycardia medical therapy

to Hospitals Treating Junctional bradycardia medical therapy

Risk calculators and risk factors for Junctional bradycardia medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2]

Overview

Treatment of junctional bradycardia depends on the severity of presentation. Atropine can be used to manage symptomatic patients.

Medical Therapy

Asymptomatic Patients

  • Among healthy patients with heightened vagal tone, no treatment is necessary

Acute Management

References

Template:WH Template:WS